Covered recipient · General Payments record
RACHEL RAGINA TAYLOR
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$1,362.84
- Reported across 68 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $468.51 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $276.93 | 16 |
| Exact Sciences Corporation | $37.13 | 2 |
| Lilly USA, LLC | $36.54 | 2 |
| Novo Nordisk AS | $34.87 | 2 |
| Indivior Inc. | $24.26 | 1 |
| Acerta Pharma LLC | $20.60 | 1 |
| Merck Sharp & Dohme Corporation | $19.96 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.95 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108292206 | CMS |
| ABBVIE INC. | $21.49 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108292208 | CMS |
| ABBVIE INC. | $8.56 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108292210 | CMS |
| ABBVIE INC. | $4.03 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108292212 | CMS |
| ABBVIE INC. | $4.29 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108292214 | CMS |
| ABBVIE INC. | $5.36 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108292216 | CMS |
| ABBVIE INC. | $5.22 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108292218 | CMS |
| ABBVIE INC. | $12.99 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108292220 | CMS |
| ABBVIE INC. | $38.76 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108292222 | CMS |
| ABBVIE INC. | $32.99 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108292224 | CMS |
| ABBVIE INC. | $21.70 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108292226 | CMS |
| ABBVIE INC. | $53.40 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108292228 | CMS |
| ABBVIE INC. | $25.09 | 10/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108292230 | CMS |
| ABBVIE INC. | $8.50 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108292232 | CMS |
| ABBVIE INC. | $10.40 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108292234 | CMS |
| ABBVIE INC. | $13.20 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108292236 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.60 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104613492 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.22 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118246667 | CMS |
| Exact Sciences Corporation | $18.16 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114549453 | CMS |
| Exact Sciences Corporation | $18.97 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114549456 | CMS |
| Indivior Inc. | $24.26 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144573195 | CMS |
| Lilly USA, LLC | $18.34 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135925026 | CMS |
| Lilly USA, LLC | $18.20 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135924638 | CMS |
| Merck Sharp & Dohme LLC | $19.96 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141955397 | CMS |
| Novo Nordisk Inc | $16.44 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100264014 | CMS |
| Novo Nordisk Inc | $18.43 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100397338 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.